Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II)
Introduction: High-grade gliomas (HGGs) still have a high rate of recurrence and lethality. Gene therapies were projected to overcome the therapeutic resilience of HGGs, due to the intrinsic genetic heterogenicity and immune evasion pathways. The present literature review strives to provide an updat...
Main Authors: | Alice Giotta Lucifero, Sabino Luzzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/11/8/976 |
Similar Items
-
Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)
by: Alice Giotta Lucifero, et al.
Published: (2021-03-01) -
Extended disease-free interval of 6 years in a recurrent glioblastoma multiforme patient treated with G207 oncolytic viral therapy
by: Whisenhunt Jr TR, et al.
Published: (2015-01-01) -
Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
by: Yogesh R. Suryawanshi, et al.
Published: (2021-07-01) -
Strategies in Gene Therapy for Glioblastoma
by: Mariano S. Viapiano, et al.
Published: (2013-10-01) -
Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
by: Brenda eAuffinger, et al.
Published: (2013-02-01)